Your current location:

Safety Pharmacology

KBI Non-GLP Safety Pharmacology studies are designed to investigate the effects of test compounds on vital functions in the nonhuman primate (NHP) at both anticipated therapeutic and supra-therapeutic exposures on major organ systems, such as the cardiovascular, central nervous, renal, and gastrointestinal systems.


Safety Pharmacology Assessments can be incorporated into our Toxicology / Safety Assessment studies, In vivo Pharmacology / Efficacy Evaluation studies and protocols, or offered as a stand-alone package.


Core and supplementary evaluations may include cardiovascular, central nervous system, renal/urinary, and gastrointestinal function assessments.


Contact us if you need more information.

Copyright © 2022 Kunming Biomed International Ltd. All Rights Reserved     |Privacy Policy|Terms of Use|
4571 Boda Road, Chenggong, Kunming, Yunnan, 650500, China